Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - August 2003

  1. Update: Multistate Outbreak of Monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003.   MMWR Morb.Mortal.Wkly.Rep.  52 (27): 642-646; July 11, 2003.

  2. The Smallpox Vaccination Program in Mississippi; a Brief History of Smallpox and Smallpox Vaccination.   Miss.RN.  65 (2): 8-9; 2003.

  3. Update: Cardiac and Other Adverse Events Following Civilian Smallpox Vaccination--United States, 2003.   MMWR Morb.Mortal.Wkly.Rep.  52 (27): 639-642; July 11, 2003.

  4. From the Centers for Disease Control and Prevention. Update: Cardiac-Related Events During the Civilian Smallpox Vaccination Program-- United States, 2003.   JAMA.  290 (1): 31-34; July 2, 2003.

  5. Summaries for Patients. Recall of Skin Diseases That Disqualify People From Preexposure Smallpox Vaccination.   Ann.Intern.Med.  139 (1): I-32; July 1, 2003.

  6. Ada, G.  Progress Towards Achieving New Vaccine and Vaccination Goals.   Intern.Med.J.  33 (7): 297-304; July, 2003.

  7. Archibald, L. K.; Kazembe, P. N.; Nwanyanwu, O.; Mwansambo, C.; Reller, L. B.; Jarvis, W. R.  Epidemiology of Bloodstream Infections in a Bacille Calmette-Guerin-Vaccinated Pediatric Population in Malawi.   J Infect.Dis.  188 (2): 202-208; July 15, 2003.

  8. Arya, S. C.  Smallpox Vaccination to Combat Bioterrorism.   Clin.Infect.Dis.  37 (1): 150-151; July 1, 2003.

  9. Baleta, A.  Sri Lanka Opens Vaccine-Safety Centre.   Lancet.  362 (9377): 49; July 5, 2003.

  10. Balinska, M. A.  Vaccination in Tomorrow's Society.   Lancet Infect.Dis.  3 (7): 443-447; July, 2003.

  11. Bridges, M. J.; Coady, D.; Kelly, C. A.; Hamilton, J.; Heycock, C.  Factors Influencing Uptake of Influenza Vaccination in Patients With Rheumatoid Arthritis.   Ann.Rheum.Dis.  62 (7): 685; July, 2003.

  12. Das, J.; Das, S.  Trust, Learning, and Vaccination: A Case Study of a North Indian Village.   Soc.Sci Med.  57 (1): 97-112; July, 2003.

  13. Esposito, S.; Marchisio, P.; Cavagna, R.; Gironi, S.; Bosis, S.; Lambertini, L.; Droghetti, R.; Principi, N.  Effectiveness of Influenza Vaccination of Children With Recurrent Respiratory Tract Infections in Reducing Respiratory-Related Morbidity Within the Households.   Vaccine.  21 (23): 3162-3168; July 4, 2003.

  14. Fishman, J. A.  Smallpox and Live-Virus Vaccination in Transplant Recipients.   Am.J Transplant.  3 (7): 786-793; July, 2003.

  15. Frazier, A.  Support for Smallpox Vaccinations.   Am.J Nurs.  103 (7): 116-117; July, 2003.

  16. Frey, C. R.; Sharp, M. A.; Min, A. S.; Schmid, D. S.; Loparev, V.; Arvin, A. M.  Identification of CD8+ T Cell Epitopes in the Immediate Early 62 Protein (IE62) of Varicella-Zoster Virus, and Evaluation of Frequency of CD8+ T Cell Response to IE62, by Use of IE62 Peptides After Varicella Vaccination.   J Infect.Dis.  188 (1): 40-52; July 1, 2003.

  17. Fulginiti, V. A.; Papier, A.; Lane, J. M.; Neff, J. M.; Henderson, D. A.  Smallpox Vaccination: A Review, Part II. Adverse Events.   Clin.Infect.Dis.  37 (2): 251-271; July 15, 2003.

  18. Fulginiti, V. A.; Papier, A.; Lane, J. M.; Neff, J. M.; Henderson, D. A.  Smallpox Vaccination: A Review, Part I. Background, Vaccination Technique, Normal Vaccination and Revaccination, and Expected Normal Reactions.   Clin.Infect.Dis.  37 (2): 241-250; July 15, 2003.

  19. Gans, H.; DeHovitz, R.; Forghani, B.; Beeler, J.; Maldonado, Y.; Arvin, A. M.  Measles and Mumps Vaccination As a Model to Investigate the Developing Immune System: Passive and Active Immunity During the First Year of Life.   Vaccine.  21 (24): 3398-3405; July 28, 2003.

  20. Gocke, K.; Baumann, U.; Hagemann, H.; Gabelsberger, J.; Hahn, H.; Freihorst, J.; von Specht, B. U.  Mucosal Vaccination With a Recombinant OprF-I Vaccine of Pseudomonas Aeruginosa in Healthy Volunteers: Comparison of a Systemic Vs. a Mucosal Booster Schedule.   FEMS Immunol.Med.Microbiol.  37 (2-3): 167-171; July 15, 2003.

  21. Halperin, S. A.; Smith, B.; Nolan, C.; Shay, J.; Kralovec, J.  Safety and Immunoenhancing Effect of a Chlorella-Derived Dietary Supplement in Healthy Adults Undergoing Influenza Vaccination: Randomized, Double-Blind, Placebo-Controlled Trial.   CMAJ.  169 (2): 111-117; July 22, 2003.

  22. Holloway, B.  Support for Smallpox Vaccinations.   Am.J Nurs.  103 (7): 116-117; July, 2003.

  23. Hurley, D.  Support for Smallpox Vaccinations.   Am.J Nurs.  103 (7): 116-117; July, 2003.

  24. Iyngkaran, P.; Limaye, V.; Hill, C.; Henderson, D.; Pile, K. D.; Rischmueller, M.  Rheumatoid Vasculitis Following Influenza Vaccination.   Rheumatology (Oxford).  42 (7): 907-909; July, 2003.

  25. Karlsen, T. H.; Sommerfelt, H.; Klomstad, S.; Andersen, P. K.; Strand, T. A.; Ulvik, R. J.; Ahren, C.; Grewal, H. M.  Intestinal and Systemic Immune Responses to an Oral Cholera Toxoid B Subunit Whole-Cell Vaccine Administered During Zinc Supplementation.   Infect.Immun.  71 (7): 3909-3913; July, 2003.

  26. Keely, J.  Support for Smallpox Vaccinations.   Am.J Nurs.  103 (7): 116-117; July, 2003.

  27. Miravalle, A.; Roos, K. L.  Encephalitis Complicating Smallpox Vaccination.   Arch.Neurol.  60 (7): 925-928; July, 2003.

  28. Naleway, A. L.; Belongia, E. A.; Greenlee, R. T.; Kieke, B. A., Jr.; Chen, R. T.; Shay, D. K.  Eczematous Skin Disease and Recall of Past Diagnoses: Implications for Smallpox Vaccination.   Ann.Intern.Med.  139 (1): 1-7; July 1, 2003.

  29. Newman, F. K.; Frey, S. E.; Blevins, T. P.; Mandava, M.; Bonifacio, A., Jr.; Yan, L.; Belshe, R. B.  Improved Assay to Detect Neutralizing Antibody Following Vaccination With Diluted or Undiluted Vaccinia (Dryvax) Vaccine.   J Clin.Microbiol.  41 (7): 3154-3157; July, 2003.

  30. Pafford-Failor, M.  Smallpox Vaccinations: A Volunteer Program in the Volunteer State.   Tenn.Nurse.  66 (2): 14-15; 2003.

  31. Pavelka, M. S., Jr.; Chen, B.; Kelley, C. L.; Collins, F. M.; Jacobs, Jr WR, Jr.  Vaccine Efficacy of a Lysine Auxotroph of Mycobacterium Tuberculosis.   Infect.Immun.  71 (7): 4190-4192; July, 2003.

  32. Pool, V.; Braun, M. M.; Kelso, J. M.; Mootrey, G.; Chen, R. T.; Yunginger, J. W.; Jacobson, R. M.; Gargiullo, P. M.  Prevalence of Anti-Gelatin IgE Antibodies in People With Anaphylaxis After Measles-Mumps Rubella Vaccine in the United States.   Pediatrics.  110 (6): e71; December, 2002.

  33. Sauerbrei, A.; Uebe, B.; Wutzler, P.  Molecular Diagnosis of Zoster Post Varicella Vaccination.   J Clin.Virol.  27 (2): 190-199; July, 2003.

  34. Saurina, G.; Shirazi, S.; Lane, J. M.; Daniel, B.; DiEugenia, L.  Myocarditis After Smallpox Vaccination: A Case Report.   Clin.Infect.Dis.  37 (1): 145-146; July 1, 2003.

  35. Skidmore, S. L.  Support for Smallpox Vaccinations.   Am.J Nurs.  103 (7): 116-117; July, 2003.

  36. Wagner, C.; Popp, W.; Posch, M.; Vlasich, C.; Rosenberger-Spitzy, A.  Impact of Pneumococcal Vaccination on Morbidity and Mortality of Geriatric Patients: A Case-Controlled Study.   Gerontology.  49 (4): 246-250; July, 2003.

  37. Wedege, E.; Kuipers, B.; Bolstad, K.; van Dijken, H.; Froholm, L. O.; Vermont, C.; Caugant, D. A.; van den, Dobbelsteen G.  Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine.   Infect.Immun.  71 (7): 3775-3781; July, 2003.

  38. Yung, B.  Influenza Vaccination Reduces Risk of Hospitalisation for Heart Disease and CVD in Subjects Aged >/=65 Years.    Thorax.  58 (7): 572; July, 2003.

Back to Top